sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
DNTH
Updated 10/6/2026, 12:42 PM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | $2,027,646 | CARR EDWARD CHIEF ACCOUNTING OFFICER | 20,000 sh | at $101.38 | Filed Sep 18, 4:36 PM ET | Filing | |
| DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | $2,460,690 | Randhawa Simrat EVP, Head of R&D | 23,124 sh | at $106.41 | Filed Sep 3, 4:30 PM ET | Filing | |
| DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | $326,554 | Read Simon Director | 2,778 sh | at $117.55 | Filed Aug 19, 6:02 PM ET | Filing | |
| DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | $844,822 | McGeorge Anne Director | 7,750 sh | at $109.01 | Filed Aug 11, 5:15 PM ET | Filing | |
| DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | $304,232 | Read Simon Director | 2,777 sh | at $109.55 | Filed Aug 11, 5:10 PM ET | Filing | |
| DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | $2,208,833 | Veness Adam M SVP, General Counsel and Sec. | 20,000 sh | at $110.44 | Filed Aug 11, 5:08 PM ET | Filing | |
| DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | $17,945,451 | Garcia Marino CEO AND PRESIDENT, Director | 166,000 sh | at $108.11 | Filed Aug 7, 6:30 PM ET | Filing | |
| DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | $3,157,151 | Savitz Ryan EVP, CFO & CBO | 31,249 sh | at $101.03 | Filed Jul 13, 5:00 PM ET | Filing |